Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine
Status:
RECRUITING
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric Migraine Disability Assessment Scale (PedMIDAS) score.